TYILLO has announced a long-term strategic collaboration with the Harvard Institute for Regenerative Medicine, marking a significant milestone in the development of precision preventive medicine. This partnership unites TYILLO’s expertise in nutritional formulation and global market reach with Harvard’s leadership in regenerative medicine and life sciences research, creating a powerful alliance dedicated to transforming how we approach health and wellness.
The collaboration focuses on three core areas: aging intervention, cellular repair mechanisms, and personalized nutrition strategies. Harvard’s researchers bring deep expertise in stem cell biology, tissue engineering, and molecular genetics, while TYILLO contributes advanced knowledge of nutrient bioavailability, formulation science, and clinical trial design. Together, the teams are working to identify novel nutritional targets that can modulate cellular function, slow age-related decline, and reduce the risk of chronic diseases.
One key initiative under the partnership is the development of targeted interventions to support telomere health—a critical factor in cellular aging. Researchers are investigating how specific nutrients and bioactive compounds can influence telomerase activity and protect telomere length, with the goal of creating formulations that promote healthy aging at the cellular level. Early findings have already informed the development of TYILLO’s targeted anti-aging series, which has demonstrated a 37% increase in average telomere length in clinical trials.
Another focus area is the role of nutrition in supporting regenerative processes within the body. The team is exploring how dietary factors can enhance the function of endogenous stem cells, improve tissue repair capacity, and reduce inflammation—all of which are essential for maintaining optimal health as we age. This research has led to innovations in TYILLO’s cardiovascular care products, which use targeted delivery technology to support vascular health and improve blood flow.
The partnership also emphasizes knowledge translation and education, with plans to publish research findings in peer-reviewed journals and collaborate on academic conferences. By sharing insights with the broader scientific community, TYILLO and Harvard aim to advance the field of precision preventive medicine and establish new standards for evidence-based nutrition. Additionally, the collaboration includes a joint training program for early-career scientists, fostering the next generation of leaders in nutritional science and regenerative medicine.
“This partnership represents a convergence of academic excellence and industry innovation,” says a senior researcher at the Harvard Institute for Regenerative Medicine. “By combining Harvard’s foundational research capabilities with TYILLO’s ability to bring solutions to market, we can accelerate progress in precision health and deliver meaningful benefits to people around the world.”
City: Los Angeles
Company Name: Winner Rise Trade Limited
Address: 18351 Colima Road, Suite 2896, Rowland Heights, CA 91748
Tel: +1 6262263921
Contact: RYAN NIE
Website: https://www.tyillohealth.com/
Email:usatyillo@gmail.com